Refine your search
Collections
Co-Authors
Journals
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Kamthe, Satish
- Prevalence of Diabetes and Hypertension among Chronic Obstructive Pulmonary Diseases Patients at a Tertiary Care Centre
Abstract Views :128 |
PDF Views:85
Authors
Nilesh Pandhari Patil
1,
Satish Kamthe
2,
Gauri Suhas Kulkarni
3,
Ramesh M. Sundrani
3,
Kamlesh Pandhari Patil
,
Japreet Singh M. Khandpur
1
Affiliations
1 Former PG Resident, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, IN
2 Former PG Resident, Department of Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, IN
3 Former Professor, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, IN
1 Former PG Resident, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, IN
2 Former PG Resident, Department of Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, IN
3 Former Professor, Department of Respiratory Medicine, Dr. Vasantrao Pawar Medical College, Hospital and Research Centre, Nashik – 422003, IN
Source
MVP Journal of Medical Sciences, Vol 8, No 1 (2021), Pagination: 112-118Abstract
Background: Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases. HT and DM have been recognized to coexist with COPD. Several risk factors have been associated with HT and DM in people with COPD: Smoking, systemic inflammation, obesity and physical inactivity. Objective: To estimate Prevalence of diabetes and hypertension in Chronic Obstructive Pulmonary Diseases amongst study participants. Material and Method: The Cross-sectional study was conducted on 161 diagnosed COPD patients from August 2017 to December 2019 in Department of Respiratory Medicine Medical College and Tertiary Health Care Institute Nashik was included. Written informed consent was taken from all study participants and those who gave consent were enrolled in the present study. Result: Out of 161 COPD patients, prevalence of hypertension was 45.96% while prevalence of DM was 22.36%. The Highest prevalence of DM in Female (33.33%), HTN in Male (48%) and both DM and HTN in Female (8.33%), active smokers were mostly associated with DM and/or HTN. In stage IV (71), DM, HTN and both DM and HTN were recorded in maximum no. of cases, whereas in patients of Stage I - COPD least level were found. Increase association of DM and/or HTN increases with severity of obstruction. Conclusion: Prevalence of HTN was recorded more than DM. DM and HTN were found to be more prevalence in severe and very severe COPD patients. The COPD patients should be screened for DM and HTN at the time of diagnosis to prevent DM and/or HTN related complications in COPD patients.Keywords
Association, COPD, DM, HTN, PrevalenceFull Text
References
- Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (Revised 2017).
- Reilly JJ, Silverman EK, Shapiro S.D. Harrison’s principles of internal medicine (16th edi. 2004; 1547–60.
- Caballero A, Torres-Duque CA, Jaramillo C. Prevalence of COPD in five Colombian cities situated at low, medium and high altitude. Chest. 2008; 1332:343–9. PMid: 17951621. https://doi.org/10.1378/chest.07-1361
- Hurd S. The impact of COPD on lung health worldwide: Epidemiology and incidence. Chest. 2000; 117 2 Suppl:1S4S. PMid: 10673465. https://doi.org/10.1378/ chest.117.2_suppl.1S
- Clini E, Crisafulli E, Radaeli A, Malerba M. COPD and the metabolic syndrome: Anintriguing association. Internal and Emergency Medicine. 2013; 8:283–9. PMid: 21964838. https://doi.org/10.1007/s11739-011-0700-x
- Nussbaumer-Ochsner Y, Rabe KF. Systemic manifestations of COPD. Chest. 2011; 139:165–73. PMid: 21208876. https://doi.org/10.1378/chest.10-1252
- Lam K-B.H, Jordan RE, Jiang CQ, Thomas GN, Miller MR, Zhang WS, Adab P. Airflow obstruction and metabolic syndrome: The Guangzhou Biobank Cohort Study. European Respiratory Journal. 2010; 35:317–23. PMid: 19574332. https://doi.org/10.1183/09031936.00024709
- Bolton CE, Evans M, Ionescu AA, Edwards SM, Morris RH, Dunseath G, Shale DJ. Insulin resistance and inflammation: A further systemic complication of COPD. Chronic Obstructive Pulmonary Disease. 2007; 4:121–6. PMid: 17530505. https://doi.org/10.1080/15412550701341053
- Arne M, Janson C, Janson S, Boman G, Lindqvist U, Berne C, Emtner M. Physical activity and qualityof life in subjects with chronic disease: Chronic Obstructive Pulmonary Disease compared with rheumatoid arthritis and Diabetes Mellitus. Scandinavian Journal of Primary Health Care. 2009; 27:141–7. PMid: 19306158 PMCid: PMC3413185. https://doi.org/10.1080/02813430902808643
- Ford ES, Li C, Zhao G. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. Journal of Diabetes. 2010; 2:180–93. PMid: 20923483. https://doi.org/10.1111/ j.1753-0407.2010.00078.x
- Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. 2005; 112:2735–52. PMid: 16157765. https://doi.org/10.1161/CIRCULATIONAHA.105.169404
- Ajit E, Bondade K, Rakesh J, Banur A, Raykar P. Prevalence of type 2 Diabetes Mellitus in Chronic Obstructive Pulmonary Disease and its impact on the severity of Chronic Obstructive Pulmonary Disease among patients attending tertiary care center in central Karnataka, Davangere. Indian J Respir Care. 2019; 8:42–5. https://doi. org/10.4103/ijrc.ijrc_42_18
- Mahishale V, Angadi N, Metgudmath V, Eti A, Lolly M, Khan S. Prevalence and impact of diabetes, hypertension and cardiovascular diseases in Chronic Obstructive Pulmonary Diseases: A hospital-based cross-section study. J Transl Intern Med. 2015; 155–60. PMid: 27847906 PMCid: PMC4936452. https://doi.org/10.1515/jtim-2015-0019
- Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008; 32:962–9. PMid: 18579551. https://doi.org/10.1183/09031936.00012408
- Singh R, Prevalence of hypertension in patients with Chronic Obstructive Pulmonary Disease attending respiratory medicine OPD. International Journal of Medical Science and Clinical Invention. 2017; 4(12):3346–8. https:// doi.org/10.18535/ijmsci/v4i12.02
- Antonelli Incalzi R, Fuso L, De Rosa M, Forastiere F, Rapiti E, Nardecchia B, Pistelli R. Co-morbidity contributes to predict mortality of patients with Chronic Obstructive Pulmonary Disease. Eur Respir J. 1997; 10:2794–800. PMid: 9493663. https://doi.org/10.1183/09031936.97.10122794
- Breyer K, Spruit A, Hanson K, Franssen M, Vanfleteren E, Groenen T, Bruijnzeel L, Wouters F, Rutten P. Prevalence of metabolic syndrome in COPD patients and its consequences. PLoS One. 2014 Jun 20; 9(6):e9801. PMid: 24950070 PMCid: PMC4064974. https://doi.org/10.1371/ journal.pone.0098013
- Park HY, Lim SY, Hwang JH, et al. Lung function, coronary artery calcification and metabolic syndrome in 4905 Koreanmales. Respir Med. 2010; 104:1326–35. PMid: 20335013. https://doi.org/10.1016/j.rmed.2010.02.024
- Marquis K, Maltais F, Duguay V, Bezeau AM, RN; LeBlanc P, Jcan Jobin J, Poirier P, et al. The metabolic syndrome in patients with Chronic Obstructive Pulmonary Disease. Journal of Cardiopulmonary Rehabilitation, 2005; 25:226–32. PMid: 16056071. https://doi.org/10.1097/ 00008483-200507000-00010
- Ravikiran M, Bhansali A, RaviKumar P, Bhansali S, Dutta P, Thakur JS, Sachdeva N, Bhadada S, Walia R. Prevalence and risk factors of metabolic syndrome among Asian Indians: A community survey. Diabetes Research and Clinical Practice. 2010; 89:181–8. PMid: 20381187. https://doi. org/10.1016/j.diabres.2010.03.010
- Ameen NM, et al, Mohamed RSED, Mageed NIAE, Wahab MHAE. The metabolic syndrome in patients with Chronic Obstructive Pulmonary Disease. Egyptian Journal of Chest Diseases and Tuberculosis. 2016; 65:593596. https://doi. org/10.1016/j.ejcdt.2016.03.008
- Almagro P, Lopez Garcia F, Cabrera F, Montero L, Morchon D, Díez J, et al. Grupo Epoc De La Sociedad Española De MedicinaInterna. Comorbidity and genderrelated differences in patients hospitalized for COPD. The ECCO study. Respir Med. 2010; 104:253–9. PMid: 19879744. https://doi. org/10.1016/j.rmed.2009.09.019
- Cazzola M, Bettoncelli G, Sessa E, et al. Prevalence of comorbidities in patients with COPD. Respiration. 2010; 80:112–9. PMid: 20134148. https://doi.org/10.1159/000281880
- Bermudez G, Gabriel Jasul Jr., David-Wang A, Jimeno C, Magallanes J, Macalalad-Josue AA. Association of Metabolic Syndrome with the Severity of Airflow Obstruction in Patients with Chronic Obstructive Pulmonary Disease. JASEAN Fed Endocr Soc. 2018; 33(2):181–7.
- Akpinar EE, Akpinar S, Ertek S, Sayin S, Gulhan M. Systemic inflammation and metabolic syndrome in stable COPD patients. Tuberk Toraks. 2012; 60(3):230–7. PMid: 23030748. https://doi.org/10.5578/tt.4018
- Comparative Outcome Study between Resolved and Unresolved St Segment in St Segment Elevation Acutemyocardial Infarction (STEMI) after Thrombolytic Therapy
Abstract Views :134 |
PDF Views:75
Authors
Affiliations
1 Former PG Resident, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Nashik - 422203, Maharashtra, India ., IN
2 Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Nashik – 422203, Maharashtra, India ., IN
3 Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Nashik – 422203, Maharashtra, India ., IN
1 Former PG Resident, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Nashik - 422203, Maharashtra, India ., IN
2 Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Nashik – 422203, Maharashtra, India ., IN
3 Professor, Department of Medicine, Dr. Vasantrao Pawar Medical College Hospital and Research Centre, Nashik – 422203, Maharashtra, India ., IN
Source
MVP Journal of Medical Sciences, Vol 9, No 1 (2022), Pagination: 24 - 29Abstract
Background: To study the comparative outcome between resolved an unresolved ST segment in ST Segment Elevation Acute Myocardial Infarction (STEMI), after thrombolytic therapy. Method: A study was carried out on patients admitted with 1st episode of ST elevated myocardial infarction in MICU of a tertiary health care center of a teaching hospital. On admission detailed history was taken and a complete clinical examination was done. Thrombolysis was done using streptokinase, 2D ECHOs were performed before and after thrombolytic therapy. Result: Most of the study population in both the group (Unresolved STEMI and Successful thrombolysis), belonged to the age group of 41 to 50 years. Co-morbidities like hypertension were present in 83% of Unresolved STEMI and 53% of Resolved STEMI. Comorbidities like diabetes were present in 66.7% of Unresolved STEMI and 52.6% of Resolved STEMI. RWMA on 2D-Echo before thrombolysis was present in 58.3% of Unresolved STEMI and 47.4% of Resolved STEMI. RWMA on 2D-Echo after thrombolysis was present in 66.7% of Unresolved STEMI and 18.5% of Resolved STEMI. Conclusion: Symptom to needle time is an important predictor of whether thrombolysis will be successful or not in acute myocardial infarction patients. Hence it is important to educate the public about prompt recognition of symptoms and seeking medical help urgently. As the rate of unsuccessful thrombolysis is higher in patients with old age, diabetes, hypertension and dyslipidemia, such patients should be monitored and treated aggressively.Keywords
Diabetes, Hypertension, RWMA - Regional Wall Motion Abnormalities, STEMI - ST Segment Elevation Myocardial Infarction, ThrombolysisFull Text
References
- World Health Organization. World Health Organization; Geneva: 2005. Preventing Chronic Diseases: A Vital Investment.
- Prevalence of Coronary Heart Disease - United States. 2006-2010. Morb Mortal Wkly Rep (MMWR). 2011; 60(40): 1377–81.
- Mohan V, Deepa R, Rani SS. Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India. J Am Coll Cardiol. 2001; 38: 682–7. https:// doi.org/10.1016/S0735-1097(01)01415-2
- Gupta R, Gupta VP, Sarna M. Prevalence of Coronary Heart Disease and risk factors in an urban Indian population: Jaipur Heart Watch-2. Indian Heart J. 2002; 54: 59–66.
- Kamili MA, Dar IH, Ali G. Prevalence of Coronary Heart Disease in Kashmiris. Indian Heart J. 2007; 61: 44–9.
- Gupta AK, Bharadwaj A, Ashotra S. Feasibility and training of multipurpose workers in detection, prevention and control of coronary artery disease in apple-belt of Shimla hills.South Asian J Prev Cardiol. 2002; 6: 17–22.
- Kumar R, Singh MC, Ahlawat SK. Urbanization and coronary heart disease: A study of urban-rural differences in Northern India. Indian Heart J. 2006; 58: 126–30.
- Ezzati M, Lopez AD, Rodgers A. World Health Organisation; Geneva: 2004. Comparative Quantification of Health Risks. Global and Regional Burden of Disease Attributable to Major Risk Factors.
- Elliot MA, Loscalzo J. ST segment elevation myocardial infarction in Longo, Fauci, Kasper, Hauser, Jameson, Loscalzo. Harrison’s principles of Internal Medicine.18h ed. New York: McGraw Hill; 2012: 2021–35.
- Elliot MA, Eugene Braunwald: STElevation MI in Libby P, Bonow RO, Zipes DP, Mann DL. BRAUNWALD’S Heart Disease. 8th ed. Philadelphia: Elsevier; 2008: 1207–300.
- Elliot MA, Eugene Braunwald: STElevation MI in Libby P, Bonow RO, Zipes DP, Mann DL. BRAUNWALD’S Heart Disease. 8th ed. Philadelphia: Elsevier; 2008: 1207-1300.
- Alexander AW, Prall CM, Ryan TJ, Robert R: ST elevation myocardial infarction in Valentine F, Alexander RW, Robert A, Robert R, Spencer B , Ira S, et al. Hurst’s The Heart. 11th ed. New York: McGraw Hill; 2004: 1277–351.
- Alexander AW, Prall CM, Ryan TJ, Robert R: ST elevation myocardial infarction in Valentine F, Alexander RW, Robert A, Robert R, Spencer B , Ira S, et al. Hurst’s The Heart. 11th ed. New York: McGraw Hill; 2004: 1277–351.
- Bajzer CT. Acute myocardial infarction. Medicine Index. Cleveland Clinic Foundation 2002: 222–6.
- Suri A, Tincey S, Ahsan S, Meier P. Thrombolysis in myocardial infarction. Lakshmanadoss U (editor), Novel Strategies in Ischemic Heart Disease, 1st edition, 2012. ISBN: 978953-51-0184-0. In Tech. 2014. Available at: http:// www.intechopen.com/books/novel-strategies-in-ischemicheartdisease/thrombolysis-in-myocardialinfarction
- Schroder R. Prognostic impact of early ST segment resolution in acute ST elevation myocardial infarction. Circulation. 2004; 110: 506–10. PMid: 15557381. https:// doi.org/10.1161/01.CIR.0000147778.05979.E6
- van’t Hof AW, Liem A, de Boer MJ, Zijlstra F. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial Infarction Study Group. Lancet. 1997; 350: 615–29. https:// doi.org/10.1016/S0140-6736(96)07120-6
- de Belder MA. Acute myocardial infarction: Failed thrombolysis. Heart. 2001; 85: 104 –12. Bajzer CT. Acute myocardial infarction. Medicine Index. Cleveland Clinic Foundation 2002: 222-26. 2. PMid: 11119477 PMCid: PMC1729601. https://doi.org/10.1136/heart.85.1.104
- Chyun DA, Young LH, Diabetes Mellitus and Cardio Vascular Disease, Nurs Clin N Am. 2006; 41: 681–95. PMid: 17059982. https://doi.org/10.1016/j.cnur.2006.07.007
- Ismail J, Jafar TH, Jafary FH, White F, Faruqui AM, et al. Risk factors for non-fatal myocardial infarction in young South Asian adults. Heart. 2004; 90: 259–63. PMid: 14966040 PMCid: PMC1768096. https://doi.org/10.1136/ hrt.2003.013631
- Enas EA, Metha J. Malignant coronary artery disease in young Asian Indians: Thoughts on pathogenesis, prevention and therapy. Coronary Artery Disease in Asian Indians CADI Study. Clin Cardio. 1995; l3: 131–5. PMid: 7743682. https://doi.org/10.1002/clc.4960180305
- Huma S, Tariq R, Amin F, Mahmood KT. Modifiable and Non-modifiable predisposing risk factors of myocardial infarction - A review. J Pharm Sci and Res. 2012; 4(1): 1649–53.
- Fresco C, Avanzini F, Bosi S. Prognostic value of a history of hypertension in 11,483 patients with acute MI treated with thrombolysis. GISSI-2 Investigators. Gruppo Italiano per lo Studio della, Sopravvivenanell’Infarto Miocardico.J Hypertens.1996; 14: 743–50. PMid: 8793697. https://doi.
- org/10.1097/00004872-199606000-00010
- Lee YY, Tee MH, Zurkurnai Y. Thrombolytic failure with streptokinase in acute myocardial infarction using electrocardiogram criteria. Singapore Med J. 2008; 49: 304–10.
- GISSI-2: In hospital mortality and clinical course of 20891 patients with suspected Acute MI randomized between alteplase and streptokinase with or without heparin. Lancet.1990; 336: 71–5. https://doi.
- org/10.1016/0140-6736(90)91590-7
- Angeja BG, Lemos J, Murphy SA, Antman EM, Cannon CP, Braunwald E. Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy. Am Heart J. 2002; 144: 649–56. PMid: 12360161. https:// doi.org/10.1016/S0002-8703(02)00136-9 https://doi. org/10.1067/mhj.2002.124869
- Chowdhury MAR, Hossain AKMM, Dey SR. A comparative study on the effect of streptokinase between diabetic and non-diabetic myocardial infarction patients. Bangladesh J Pharmacol. 2008; 3: 1–7. https://doi.org/10.3329/bjp. v3i1.822
- Kharash LM, Gol’dkhammer EI, Abinader EG. The clinical aspects of thrombolytic therapy with streptokinase in myocardial infarct. Ter Arkh.1996; 68(12): 53–7.
- Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute MI: A quantitative review of 23 randomized trials. Lancet. 2003; 361: 13–20 https://doi.org/10.1016/S0140-6736(03)12113-7
- GISSI- 2: In hospital mortality and clinical course of 20891 patients with suspected Acute MI randomized between alteplase and streptokinase with or without heparin. Lancet.1990; 336: 71–5. https://doi. org/10.1016/0140-6736(90)91590-7
- Shah A, Galen SW, Christopher BG, Christopher MO, Cynthia LG, Kathleen MT, et al. Prognostic implications of TIMI flow grade in infarct related artery compared with 12 lead ST segment resolution analysis. J Am Coll Cardio. 2000; 35: 666–72. https://doi.org/10.1016/S0735-
- (99)00601-4
- Gabriel IB, Arie R, Hanoch H, Hilton IM, Schemuel R, Yedahel HZ, et al. Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase. Heart. 1990; 64: 241–7. PMid: 2121199 PMCid: PMC1024413. https://doi.org/10.1136/hrt.64.4.241 .